With MMR and flu, views of science and scientists largely explain the partisan gap in perceptions of vaccines,
press release on 2024 vaccine survey study
“With Covid-19 they don’t. Something beyond how people see science and scientists is shaping how Democrats and Republicans judge that vaccine.”
“Novartis now expects to speak with the FDA about a potential accelerated approval of pelabresib before the end of the year, CEO Vas Narasimhan told investors on a call Tuesday.”
“The industry has gotten more consolidated. Prices are higher than ever. Access is worse than ever.”
“The rising costs are unsustainable for individuals, for businesses, and for the country. What kind of intervention is a different question.”